Dr. Clayton P Wells, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 94 Boardwalk, Inez, KY 41224 Phone: 606-298-2080 |
Alison Tegan Cox Maynard, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 Rockcastle Road, Inez, KY 41224 Phone: 606-298-4215 |
Megan Mellert Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 Rockcastle Rd, Inez, KY 41224 Phone: 606-298-7271 |
Mrs. Patricia Elizabeth Johnson, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 Rockcastle Road, Inez, KY 41224 Phone: 606-298-4215 Fax: 606-298-3101 |
Jeremy Horn, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 94 Boardwalk, Inez, KY 41224 Phone: 606-298-2080 Fax: 606-298-2081 |
Dr. Amanda Lee Barber, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2160 Blacklog Rd Ste 100, Inez, KY 41224 Phone: 606-298-7283 Fax: 606-298-4538 |
News Archive
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol), a standard chemotherapy regimen, will be presented during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) being held December 8-12, 2010 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
A team of scientists in France recently developed a mouse-adapted strain of SARS-CoV-2 that efficiently replicates in the lungs of standard laboratory mice and induces mild to moderate disease. The study is currently available on the bioRxiv* preprint server.
VirtualScopics, Inc. (Nasdaq: VSCP), a leading provider of quantitative imaging for clinical trials, today announced its financial results for the quarter and six months ended June 30, 2009.
A new state-of-the-art research facility dedicated to helping produce modified cells for treatment of cancer and other diseases recently opened at the Siteman Cancer Center.
› Verified 2 days ago